Skip to content

Clinical study of Thunder-fire Moxibustion to Improve Cancer Related Fatigue in Breast Cancer Survivors

Clinical study of Thunder-fire Moxibustion to Improve Cancer Related Fatigue in Breast Cancer Survivors

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072277
Enrollment
Unknown
Registered
2023-06-08
Start date
2022-03-20
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Related Fatigue in Breast Cancer Survivors

Interventions

Control group:Conventional treatment
Experimental group:Conventional treatment combined with Thunder-fire Moxibustion

Sponsors

Neijiang Hospital of Traditional Chinese Medicine affiliated to Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) meet the diagnostic criteria for carcinogenic fatigue in the International Classification of Diseases, version 10 (ICD-10); 2) moderate to severe fatigue, defined as a score of = 4 on the PiPer Fatigue Scale; 3) Women diagnosed with stage I-III breast cancer; 4) Be between 18 and 80 years old; 5) Karnofsky Functional Status (KPS) score= 70; 6) Have completed breast cancer treatment (surgery, radiotherapy, chemotherapy, targeted therapy) for at least 12 weeks, but endocrine therapy is allowed to be ongoing and more than 4 weeks.

Exclusion criteria

Exclusion criteria: 1) Pregnant and lactating women; 2) Patients with mental or cognitive disorders; 3) Anemia (hemoglobin 22pmol/L, thyroid-stimulating hormone >5.0uIU/ml); 5) Abnormal liver and kidney function test results (aspartate aminotransferase or alanine aminotransferase exceeds the upper limit of the normal range by 2 times, creatinine exceeds the upper limit of the normal range by 1.5 times).

Design outcomes

Primary

MeasureTime frame
Piper Fatigue Scale score;

Secondary

MeasureTime frame
Karnofsky Performance Scale score;IL-8;IL-6;

Countries

China

Contacts

Public ContactXu Bo

Neijiang Hospital of Traditional Chinese Medicine affiliated to Chengdu University of Traditional Chinese Medicine

xubo980512@163.com+86 181 8131 0707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026